Pharma-Bio Serv (PBSV) Receivables - Net (2016 - 2025)
Historic Receivables - Net for Pharma-Bio Serv (PBSV) over the last 17 years, with Q4 2025 value amounting to $5.3 million.
- Pharma-Bio Serv's Receivables - Net rose 11107.89% to $5.3 million in Q4 2025 from the same period last year, while for Oct 2025 it was $5.3 million, marking a year-over-year increase of 11107.89%. This contributed to the annual value of $5.3 million for FY2025, which is 0.0% changed from last year.
- Per Pharma-Bio Serv's latest filing, its Receivables - Net stood at $5.3 million for Q4 2025, which was up 11107.89% from $2.0 million recorded in Q3 2025.
- Over the past 5 years, Pharma-Bio Serv's Receivables - Net peaked at $10.4 million during Q2 2021, and registered a low of $520000.0 during Q4 2021.
- Its 5-year average for Receivables - Net is $5.1 million, with a median of $5.0 million in 2022.
- Per our database at Business Quant, Pharma-Bio Serv's Receivables - Net crashed by 9465.44% in 2021 and then surged by 85817.31% in 2022.
- Quarter analysis of 5 years shows Pharma-Bio Serv's Receivables - Net stood at $520000.0 in 2021, then soared by 858.17% to $5.0 million in 2022, then fell by 20.91% to $3.9 million in 2023, then crashed by 36.29% to $2.5 million in 2024, then skyrocketed by 111.08% to $5.3 million in 2025.
- Its Receivables - Net was $5.3 million in Q4 2025, compared to $2.0 million in Q3 2025 and $5.3 million in Q2 2025.